BioSpace News Archive

Seed round was led by M Ventures and INKEF Capital, and co-led by Taiho Ventures and Bioqube Ventures

Immunovia is launching its IMMray™ PanCan-d test in the US as a Laboratory Developed Test in Q2 2021.

HMNC Brain Health, a biotech company focused on the development of innovative and personalized treatments for depression and other neuropsychiatric disorders, enters a new phase of growth with a new leadership team.

Axonics, Inc., a global medical technology company that has developed and is commercializing novel products for the treatment of bladder and bowel dysfunction, is scheduled to participate in the BofA Securities 2021 Virtual Healthcare Conference on Thursday, May 13, 2021.

Evelo Biosciences, a clinical stage biotechnology company developing a new modality of orally delivered medicines, announced that it will host a conference call and live webcast at 8:30 a.m. ET on Thursday, April 29, 2021 to report its first quarter 2021 financial results and discuss business highlights.

NeuroMetrix, Inc. reported financial and business highlights for the quarter ended March 31, 2021.

YTX-7739 is Yumanity’s lead product candidate in clinical development for the treatment of Parkinson’s disease

via NewMediaWire ‒ Progressive Care Inc., a personalized healthcare services and technology company, is pleased to announce that the Company has gained access to a large inventory of Moderna vaccine doses and will begin immediate distribution to PharmCo customers through both in-store and on-location vaccinations.

In recognition of Earth Day, BD, a leading global medical technology company, reinforces its commitment to Advancing the world of health™ by affirming the first phase of its 2030+ sustainability goals – climate change targets.

Codiak BioSciences, Inc., a clinical-stage company focused on pioneering the development of exosome-based therapeutics as a new class of medicines, announced the online publication of a new manuscript, exoSTING, an extracellular vesicle loaded with STING agonists, promotes tumor immune surveillance, in Communications Biology, a Nature Research publication.